All Stories

  1. Targeting the stringent response alters gene expression and extracellular vesicle RNA in Staphylococcus aureus
  2. Recent advances in gold and zinc oxide nanoparticles: Antibiofilm action, mechanisms beyond ROS generation, and in vivo efficacy
  3. Protocol for a murine skin abscess model to study bacterial infection dynamics, microbial interactions, and treatment efficacy
  4. Inhaled Antibiotic and Biologic Formulations Targeting Pseudomonas aeruginosa
  5. Advanced antimicrobial peptide-based biomaterials for food safety applications
  6. Host-inspired anti-virulence strategies against membrane-targeting bacterial toxins: modification and mimicry
  7. Cell-Derived Nanocarriers of Apoptotic Bodies with an Antimicrobial Peptide for Targeting Intracellular S. aureus Infections
  8. Intranasal phage therapy overcomes antibody neutralization challenges in pulmonary Pseudomonas aeruginosa infections
  9. Antiparasitic effect of peptoids against Cryptosporidium parvum
  10. A review of recently discovered mechanisms of cephalosporin resistance in Pseudomonas aeruginosa
  11. Synthetic host defense peptide inhibits SARS-CoV-2 replication in vitro
  12. Targeting biofilms with novel peptides
  13. Azithromycin represses evolution of ceftazidime/avibactam resistance by translational repression of rpoS in Pseudomonas aeruginosa
  14. Comparative lipidomics profiles of planktonic and biofilms of methicillin-resistant and -susceptible Staphylococcus aureus
  15. Editorial: Reviews in microbial pathogenesis
  16. DJK-5, an anti-biofilm peptide, increases Staphylococcus aureus sensitivity to colistin killing in co-biofilms with Pseudomonas aeruginosa
  17. Pressure injuries and biofilms: Microbiome, model systems and therapies
  18. Gold nanoparticles as innovative therapeutics for oral mucositis: A review of current evidence
  19. Phage cocktail amikacin combination as a potential therapy for bacteremia associated with carbapenemase producing colistin resistant Klebsiella pneumoniae
  20. Allenamides as a Powerful Tool to Incorporate Diversity: Thia‐Michael Lipidation of Semisynthetic Peptides and Access to β‐Keto Amides
  21. Allenamides as a Powerful Tool to Incorporate Diversity: Thia‐Michael Lipidation of Semisynthetic Peptides and Access to β‐Keto Amides
  22. From Data to Decisions: Leveraging Artificial Intelligence and Machine Learning in Combating Antimicrobial Resistance – a Comprehensive Review
  23. Antiparasitic effect of peptoids againstCryptosporidium parvum
  24. Current and novel therapies for management of Acinetobacter baumannii -associated pneumonia
  25. Site-Specific Antimicrobial Activity of a Dual-Responsive Ciprofloxacin Prodrug
  26. Using host-mimicking conditions and a murine cutaneous abscess model to identify synergistic antibiotic combinations effective against Pseudomonas aeruginosa
  27. Biodistribution of Native and Nanoformulated Innate Defense Regulator Peptide 1002
  28. Murepavadin promotes the killing efficacies of aminoglycoside antibiotics against Pseudomonas aeruginosa by enhancing membrane potential
  29. Repurposing ebselen as an inhalable dry powder to treat respiratory tract infections
  30. Effectiveness of gold nanoparticles in prevention and treatment of oral mucositis in animal models: a systematic review
  31. Size-Controlled Synthesis of Gold Nanoparticles Tethering Antimicrobial Peptides with Potent Broad-Spectrum Antimicrobial and Antibiofilm Activities
  32. Novel intranasal phage-CaEDTA-ceftazidime/avibactam triple combination therapy demonstrates remarkable efficacy in treating Pseudomonas aeruginosa lung infection
  33. Murepavadin induces envelope stress response and enhances the killing efficacies of β-lactam antibiotics by impairing the outer membrane integrity of Pseudomonas aeruginosa
  34. Surviving the host: Microbial metabolic genes required for growth of Pseudomonas aeruginosa in physiologically-relevant conditions
  35. The ColR/S two-component system is a conserved determinant of host association across Pseudomonas species
  36. Inhalable ceftazidime-roflumilast powder targeting infection and inflammation: Influence of incorporating roflumilast into ceftazidime-leucine co-amorphous formulation
  37. Three-Dimensional Printed Cellulose for Wound Dressing Applications
  38. Biodistribution and toxicity of innate defense regulator 1018 (IDR-1018)
  39. Targeting the Pseudomonas aeruginosa Virulence Factor Phospholipase C With Engineered Liposomes
  40. Self-Assembly of Antimicrobial Peptoids Impacts Their Biological Effects on ESKAPE Bacterial Pathogens
  41. Antibiofilm and immunomodulatory resorbable nanofibrous filing for dental pulp regenerative procedures
  42. Ultraviolet-C Irradiation, Heat, and Storage as Potential Methods of Inactivating SARS-CoV-2 and Bacterial Pathogens on Filtering Facepiece Respirators
  43. 3D printed cellulose based product applications
  44. Cellulose composites containing active constituents of coffee and tea: a prospective novel wound dressing
  45. The ColR/S two-component system is a conserved determinant of host association across Pseudomonas species
  46. Enzymatically releasable polyethylene glycol – host defense peptide conjugates with improved activity and biocompatibility
  47. Synergistic bactericidal activities of tobramycin with ciprofloxacin and azithromycin against Klebsiella pneumoniae
  48. Peptide 1018 inhibits swarming and influences Anr-regulated gene expression downstream of the stringent stress response in Pseudomonas aeruginosa
  49. Treatment with a neutrophil elastase inhibitor and ofloxacin reduces P. aeruginosa burden in a mouse model of chronic suppurative otitis media
  50. Murine Model of Sinusitis Infection for Screening Antimicrobial and Immunomodulatory Therapies
  51. Friends or enemies? The complicated relationship between Pseudomonas aeruginosa and Staphylococcus aureus
  52. Human organoid biofilm model for assessing antibiofilm activity of novel agents
  53. Towards understanding single-channel characteristics of OccK8 purified from Pseudomonas aeruginosa
  54. Rapid microwave-based method for the preparation of antimicrobial lignin-capped silver nanoparticles active against multidrug-resistant bacteria
  55. Contribution of swarming motility to dissemination in a Pseudomonas aeruginosa murine skin abscess infection model
  56. Identification of novel targets of azithromycin activity against Pseudomonas aeruginosa grown in physiologically relevant media
  57. Host Defense Peptide-Mimicking Amphiphilic β-Peptide Polymer (Bu:DM) Exhibiting Anti-Biofilm, Immunomodulatory, and in Vivo Anti-Infective Activity
  58. Mechanistic Understanding Enables the Rational Design of Salicylanilide Combination Therapies for Gram-Negative Infections
  59. A cyclic derivative of host-defence peptide IDR-1018 improves proteolytic stability, suppresses inflammation, and enhances in vivo activity
  60. The Stringent Stress Response Controls Proteases and Global Regulators under Optimal Growth Conditions in Pseudomonas aeruginosa
  61. A novel mouse model of chronic suppurative otitis media and its use in preclinical antibiotic evaluation
  62. The stringent stress response controls proteases and global regulators under optimal growth conditions in Pseudomonas aeruginosa
  63. Rough-type and loss of the LPS due to lpx genes deletions are associated with colistin resistance in multidrug-resistant clinical Escherichia coli isolates not harbouring mcr genes
  64. NtrBC Regulates Invasiveness and Virulence of Pseudomonas aeruginosa During High-Density Infection
  65. Mechanistic understanding enables the rational design of salicylanilide combination therapies for Gram-negative infections
  66. Surfing motility is a complex adaptation dependent on the stringent stress response in Pseudomonas aeruginosa LESB58
  67. Hyaluronic acid-based nanogels improve in vivo compatibility of the anti-biofilm peptide DJK-5
  68. Dismantling the bacterial virulence program
  69. Controlling biofilm formation with nitroxide functional surfaces
  70. Aurein-derived antimicrobial peptides formulated with pegylated phospholipid micelles to target methicillin-resistant Staphylococcus aureus skin infections
  71. Is synergy the key to treating high-density infections?
  72. Synergy between conventional antibiotics and anti-biofilm peptides in a murine, sub-cutaneous abscess model caused by recalcitrant ESKAPE pathogens
  73. Liposomal Therapy Attenuates Dermonecrosis Induced by Community-Associated Methicillin-Resistant Staphylococcus aureus by Targeting α-Type Phenol-Soluble Modulins and α-Hemolysin
  74. Helicobacter pylori Biofilm Formation Is Differentially Affected by Common Culture Conditions, and Proteins Play a Central Role in the Biofilm Matrix
  75. TonB-Dependent Receptor Repertoire of Pseudomonas aeruginosa for Uptake of Siderophore-Drug Conjugates
  76. Impact of Host Defense Peptides on Chronic Wounds and Infections
  77. New Perspectives in Biofilm Eradication
  78. Alternative strategies to fight drug resistant bacteria in an abscess infection model
  79. Alternative strategies for the study and treatment of clinical bacterial biofilms
  80. A Single Residue Acts as Gate in OccK Channels
  81. New Mouse Model for Chronic Infections by Gram-Negative Bacteria Enabling the Study of Anti-Infective Efficacy and Host-Microbe Interactions
  82. Structure and Function of the PiuA and PirA Siderophore-Drug Receptors from Pseudomonas aeruginosa and Acinetobacter baumannii
  83. Mechanisms of intrinsic resistance and acquired susceptibility of Pseudomonas aeruginosa isolated from cystic fibrosis patients to temocillin, a revived antibiotic
  84. The bacteriophage‐derived transcriptional regulator, LscR, activates the expression of levansucrase genes in Pseudomonas syringae
  85. Anti-biofilm peptides as a new weapon in antimicrobial warfare
  86. Bacterial Abscess Formation Is Controlled by the Stringent Stress Response and Can Be Targeted Therapeutically
  87. Draft Genome Sequence of Dietzia maris DSM 43672, a Gram-Positive Bacterium of the Mycolata Group
  88. Antibiofilm Peptides: Potential as Broad-Spectrum Agents
  89. Swarming motility is modulated by expression of the putative xenosiderophore transporter SppR-SppABCD in Pseudomonas aeruginosa PA14
  90. Marinobacter adhaerens HP15 harbors two CzcCBA efflux pumps involved in zinc detoxification
  91. The Pseudomonas aeruginosa PA14 ABC Transporter NppA1A2BCD Is Required for Uptake of Peptidyl Nucleoside Antibiotics
  92. Role of the cell envelope stress regulators BaeR and CpxR in control of RND-type multidrug efflux pumps and transcriptional cross talk with exopolysaccharide synthesis in Erwinia amylovora
  93. Expression of extra-cellular levansucrase in Pseudomonas syringae is controlled by the in planta fitness-promoting metabolic repressor HexR
  94. Identification, characterization, isolation and activity against Escherichia coli of quince (Cydonia oblonga) fruit polyphenols
  95. High-Throughput Screening of Dipeptide Utilization Mediated by the ABC Transporter DppBCDF and Its Substrate-Binding Proteins DppA1-A5 in Pseudomonas aeruginosa
  96. AraC/XylS Family Stress Response Regulators Rob, SoxS, PliA, and OpiA in the Fire Blight Pathogen Erwinia amylovora
  97. Characterization and regulation of the Resistance-Nodulation-Cell Division-type multidrug efflux pumps MdtABC and MdtUVW from the fire blight pathogen Erwinia amylovora
  98. Characterization of AcrD, a Resistance-Nodulation-Cell Division-type multidrug efflux pump from the fire blight pathogen Erwinia amylovora
  99. Enhanced expression of codon optimized Mycobacterium avium subsp. paratuberculosis antigens in Lactobacillus salivarius
  100. The conserved upstream region of lscB/C determines expression of different levansucrase genes in plant pathogen Pseudomonas syringae
  101. Codon optimisation to improve expression of aMycobacterium aviumssp.paratuberculosis-specific membrane-associated antigen byLactobacillus salivarius
  102. Phylogenetic detection of horizontal gene transfer during the step-wise genesis of Mycobacterium tuberculosis